Invus Public Equities, L.P. 13D and 13G filings for Kalaris Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-29 1:21 pm Purchase |
2025-06-30 | 13G | Kalaris Therapeutics Inc KLRS |
Invus Public Equities, L.P. | 282,586 1.500% |
282,586 (New Position) |
Filing |